'Screen and treat' approach to prevent type 2 diabetes unlikely to have major impact

January 4, 2017

"Screen and treat" policies to preventing type 2 diabetes are unlikely to have substantial impact on this growing epidemic, concludes a study published by The BMJ today.

The prevalence of type 2 is rising globally. In the UK, for example, about 3.2 million people have the condition and by 2025 it is predicted that this will increase to five million, at an estimated cost of £23.7bn ($30.2bn, €28.2bn) to the NHS.

There are two approaches to prevention: screen and treat, in which people are identified as "" and offered individual intervention, and a population-wide approach, in which everyone is targeted via public health policies. The UK's National Diabetes Prevention Programme follows Australia and the United States in placing the emphasis on a screen and treat approach.

But this approach will be effective only if a test exists that correctly identifies those at high risk (sensitivity) while also excluding those at low risk (specificity); and an intervention exists that is acceptable to patients and clinicians.

So a team of researchers, led by Professor Trish Greenhalgh at the University of Oxford, assessed the diagnostic accuracy of screening tests for pre-diabetes (high risk of developing type 2 diabetes in the future) and effectiveness of interventions in preventing onset of type 2 diabetes in people with pre-diabetes.

They analysed the results of 49 studies of screening tests and 50 intervention trials.

Screening tests included fasting plasma glucose (higher than levels after a period of fasting) and raised glycated haemoglobin or HbA1c (proportion of with glucose attached, indicating over the previous 2-3 months).

Interventions were lifestyle change or treatment with metformin (a drug that helps lower ).

They found that the of tests used to detect pre-diabetes in screening programmes was low - fasting glucose is specific but not sensitive and HbA1c is neither sensitive nor specific - suggesting that large numbers of people will be unnecessarily treated or falsely reassured depending on the test used.

Lifestyle interventions lasting three to six years showed a 37% reduction in relative risk of type 2 diabetes, equating to 151 out of 1000 people developing diabetes compared with 239 of 1000 in the control group. This fell to 20% in follow up studies.

Use of metformin showed a relative risk reduction of 26% while participants were taking this drug, translating to 218 out of 1000 developing diabetes while taking metformin compared with 295 of 1000 not receiving it.

The authors warn that study quality was often low and results may have been affected by bias (problems in study design that can influence results).

They conclude that "screen and treat" policies will benefit some but not all people at high risk of developing diabetes, and they should be complemented by population-wide approaches for effective diabetes prevention.

In a linked editorial, Professor Norman Waugh from Warwick Medical School says adherence to across whole populations is the key to prevention of type 2 diabetes.

He points out that "pre-diabetes" is an unsatisfactory term because many people so labelled do not develop diabetes, and believes there is a balance to be struck between the medical model of screening and treating of individuals of individuals, and the public health model of changing behaviour in the whole population at risk.

He says measures targeted at the whole population at risk could include interventions to help weight control, such as changes to taxation of foodstuffs and interventions to make physical activity easier or safer.

However, he acknowledges that adherence to lifestyle advice remains poor, and concludes that preventing or delaying type 2 diabetes "requires effective measures to motivate the general population to protect their own health."

Explore further: Low testosterone thresholds established for type 2 diabetes

More information: Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions, The BMJ, www.bmj.com/cgi/doi/10.1136/bmj.i6538

Editorial: Screen and intervene to prevent diabetes? The BMJ www.bmj.com/cgi/doi/10.1136/bmj.i6800

Related Stories

Low testosterone thresholds established for type 2 diabetes

August 25, 2016
Research into type 2 diabetes conducted by Western Sydney University has for the first time established a range of clinical thresholds for testosterone levels in men associated with developing diabetes.

Interventions lower diabetes risk in women who had gestational diabetes

February 23, 2015
Women with a history of gestational diabetes face a heightened risk of developing Type 2 diabetes for years after giving birth, but intensive lifestyle intervention or a medication regimen can have a protective effect in ...

Stepwise program can reduce diabetes incidence

August 12, 2016
(HealthDay)—A culturally-tailored stepwise diabetes prevention program can reduce incidence of diabetes among overweight/obese Asian Indian adults, according to a study published online Aug. 8 in Diabetes Care.

Study supports lower cut-off point for defining prediabetes

November 23, 2016
The health risks and mortality associated with prediabetes seem to increase at the lower cut-off point for blood sugar levels recommended by some guidelines, finds a large study published in The BMJ today.

Better definition of 'pre-diabetes' can help identify those at risk for long-term complications

November 17, 2016
Defining pre-diabetes based on hemoglobin A1C, a common test that determines a long-term average blood sugar level, is the most accurate predictor of who will go on to develop long-term complications from diabetes, new Johns ...

A better way to predict diabetes

June 23, 2016
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery. The discovery would allow health care providers ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.